Showing results (441-450 of 476) with videos related to

Sort By:
Pageof 48
Science Advances|May 11, 2022
Microglial GPR56 is the molecular target of maternal immune activation-induced parvalbumin-positive interneuron deficitsDiankun Yu, Tao Li, Jean-Christophe Delpech, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research HospitalS L Spunt, C A Poquette, Y S Hurt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Ifosfamide in pediatric malignant solid tumorsC B Pratt, E C Douglass, E L Etcubanas, et al.
Elife|August 24, 2014
A molecular mechanism of mitotic centrosome assembly in DrosophilaPaul T Conduit, Jennifer H Richens, Alan Wainman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomasJ F Kuttesch, L H Wexler, R B Marcus, et al.
The Annals of Thoracic Surgery|December 26, 2017
Risk Modeling to Optimize Patient Selection for Management of the Descending Thoracic Aortic AneurysmAkiko Tanaka, Harleen K Sandhu, Wande B Pratt, et al.
Journal of Pediatric Surgery|October 6, 1997
Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcomaE L Michalkiewicz, B N Rao, E Gross, et al.
Medical and Pediatric Oncology|February 25, 1998
Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group studyC B Pratt, H M Maurer, P Gieser, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumorsW C Zamboni, L C Bowman, M Tan, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumorsAarif Ahsan, Susmita G Ramanand, Christopher Whitehead, et al.
Pageof 48